Outcomes of 28+1 to 32+0 weeks gestation babies in the state of Qatar: finding facility-based cost effective options for improving the survival of preterm neonates in low income countries.

International Journal of Environmental Research and Public Health
Hussain ParappilWalid El Ansari

Abstract

In this retrospective study we did a comparative analysis of the outcome of 28(+1) to 32(+0) weeks gestation babies between the State of Qatar and some high income countries with an objective of providing an evidence base for improving the survival of preterm neonates in low income countries. Data covering a five year period (2002-2006) was ascertained on a pre-designed Performa. A comparative analysis with the most recent data from VON, NICHD, UK, France and Europe was undertaken. Qatar's 28(+1) to 32(+0) weeks Prematurity Rate (9.23 per 1,000 births) was less than the UK's (p < 0.0001). Of the 597 babies born at 28(+1) to 32(+0) weeks of gestation, 37.5% did not require any respiratory support, while 31.1% required only CPAP therapy. 80.12% of the MV and 96.28% of CPAP therapy was required for <96 hours. 86.1% of the mothers had received antenatal steroids. The 28(+1) to 32(+0) weeks mortality rate was 65.3/1,000 births with 30.77% deaths attributable to a range of lethal congenital and chromosomal anomalies. The survival rate increased with increasing gestational age (p < 0.001) and was comparable to some high income countries. The incidence of in hospital pre discharge morbidities in Qatar (CLD 2.68%, IVH Grade III 0.84%, I...Continue Reading

References

Oct 2, 2002·Journal of Paediatrics and Child Health·J R BowenP J Hand
Feb 24, 2004·Archives of Disease in Childhood. Fetal and Neonatal Edition·B LarroqueUNKNOWN Epipage stusy group
Mar 9, 2005·Lancet·Joy E LawnUNKNOWN Lancet Neonatal Survival Steering Team
Mar 16, 2005·Lancet·Gary L DarmstadtUNKNOWN Lancet Neonatal Survival Steering Team
Mar 23, 2005·Lancet·Rudolf KnippenbergUNKNOWN Lancet Neonatal Survival Steering Team
Mar 30, 2005·Lancet·Jose MartinesUNKNOWN Lancet Neonatal Survival Steering Team
May 4, 2005·Pediatrics·Trond MarkestadUNKNOWN Norwegian Extreme Prematurity Study Group
Nov 3, 2005·Pediatrics·Lindsay A ThompsonThérèse A Stukel
Jan 18, 2006·Seminars in Fetal & Neonatal Medicine·Viviana MangiaterraErika Dunkelberg
Aug 17, 2006·Paediatric and Perinatal Epidemiology·Abdulbari Bener, Rafat Hussain
Jan 9, 2007·BJOG : an International Journal of Obstetrics and Gynaecology·S P Verloove-Vanhorick
Feb 20, 2007·American Journal of Obstetrics and Gynecology·Avroy A FanaroffUNKNOWN NICHD Neonatal Research Network
Jun 15, 2007·Maternal and Child Health Journal·Emile Papiernik
Aug 23, 2007·Archives of Disease in Childhood. Fetal and Neonatal Edition·Louise S OwenPeter G Davis
Sep 23, 2008·Archives of Disease in Childhood. Fetal and Neonatal Edition·E S DraperUNKNOWN MOSAIC research group
Jun 6, 2009·Italian Journal of Pediatrics·Giuseppe De NisiAlberta Valente

❮ Previous
Next ❯

Citations

Mar 1, 2012·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Hercília GuimarãesGiuseppe Buonocore
Jul 12, 2011·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Hercilia GuimarãesGiuseppe Buonocore
Oct 27, 2015·Frontiers in Public Health·Selina ChowJelena Popovic

❮ Previous
Next ❯

Methods Mentioned

BETA
SGA
NMR

Software Mentioned

Performa
Vassar stat
Fiji

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.